F6T Analyst Ratings
Moderate Buy
4 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
F6T Stock 12 Month Forecast
Average Price Target
€5.89
▲(179.16% Upside)
| Highest Price Target€7.03 | Average Price Target€5.89 | Lowest Price Target€3.08 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Piper Sandler
€5.27→€7.03
Buy
233.32%
Upside
Reiterated
08/14/26
TD Cowen
―
Hold
―
Reiterated
08/13/26
Needham
―
Hold
―
Reiterated
08/13/26
H.C. Wainwright
€6.15
Buy
191.65%
Upside
Reiterated
07/09/26
Bank of America Securities
€1.76→€1.93
Hold
-8.34%
Downside
Reiterated
05/21/26
Jefferies
€3.52
Buy
66.66%
Upside
Initiated
05/19/26
Barclays
€1.76
Buy
-16.67%
Downside
Reiterated
10/28/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Piper Sandler
€5.27→€7.03
Buy
233.32%
Upside
Reiterated
08/14/26
TD Cowen
―
Hold
―
Reiterated
08/13/26
Needham
―
Hold
―
Reiterated
08/13/26
H.C. Wainwright
€6.15
Buy
191.65%
Upside
Reiterated
07/09/26
Bank of America Securities
€1.76→€1.93
Hold
-8.34%
Downside
Reiterated
05/21/26
Jefferies
€3.52
Buy
66.66%
Upside
Initiated
05/19/26
Barclays
€1.76
Buy
-16.67%
Downside
Reiterated
10/28/25
Best Analysts Covering Fate Therapeutics
3 Months
Success Rate
5/11 ratings generated profit
Average Return
-3.76%
Copying Edward Tenthoff's trades and holding each position for 3 Months would result in 45.45% of your transactions generating a profit, with an average return of -3.76% per trade.
1 Year
Success Rate
6/11 ratings generated profit
Average Return
+13.71%
Copying Edward Tenthoff's trades and holding each position for 1 Year would result in 54.55% of your transactions generating a profit, with an average return of +13.71% per trade.
2 Years
Success Rate
8/11 ratings generated profit
Average Return
+35.40%
Copying Edward Tenthoff's trades and holding each position for 2 Years would result in 72.73% of your transactions generating a profit, with an average return of +35.40% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
F6T Analyst Recommendation Trends
Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
5
10
11
9
4
Buy
0
0
0
0
0
Hold
5
5
6
5
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
10
15
17
14
8
Each month's total comprises the sum of three months' worth of ratings.
F6T Financial Forecast
F6T Stock Forecast FAQ
What is DE:F6T’s average 12-month price target, according to analysts?
Based on analyst ratings, Fate Therapeutics’s 12-month average price target is 5.89.
What is DE:F6T’s upside potential, based on the analysts’ average price target?
Fate Therapeutics has 179.16% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Fate Therapeutics a Buy, Sell or Hold?
Fate Therapeutics has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 3 hold ratings and 0 sell ratings.
What is Fate Therapeutics’s share price target?
The average share price target for Fate Therapeutics is 5.89. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €7.03 ,and the lowest forecast is €3.08. The average share price target represents 179.16% Increase from the current price of €2.11.
The highest analyst share price target is €7.03 ,and the lowest forecast is €3.08. The average share price target represents 179.16% Increase from the current price of €2.11.
What do analysts say about Fate Therapeutics?
Fate Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.
How can I buy shares of Fate Therapeutics?
To buy shares of DE:F6T, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.